loader
Please Wait
Applying Filters...
FDA_Warning_Letters, Import_Alerts_&_EU_Non-Compliances_in_2019
X

Alkermes Plc's list of EU CTD Dossiers, Marketing Authorizations, In, Out Licensing Opportunities & Finished Dosage Formulations aggregated by PharmaCompass

Client EmailClient Virtual Booth
Left Arrow
Right Arrow
Filters Filter
×
FILTER DATA :

filter

ALKERMES

ALKERMES GAINESVILLE

ALKERMES INC

filter

ARIPIPRAZOLE LAUROXIL

ISOSORBIDE MONONITRATE

KETOPROFEN

NALTREXONE

filter

CAPSULE, EXTENDED RELEASE;ORAL

FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR

TABLET, EXTENDED RELEASE;ORAL

filter

1064MG/3.9ML (272.82MG/ML)

200MG

380MG/VIAL

441MG/1.6ML (275.63MG/ML)

60MG

662MG/2.4ML (275.83MG/ML)

675MG/2.4ML

882MG/3.2ML (275.63MG/ML)

filter

USA

SUSPENSION, EXTENDED R...
441MG/1.6ML (275.63MG/...
ARISTADA
USA
207533
2015-10-05
RX
SUSPENSION, EXTENDED R...
662MG/2.4ML (275.83MG/...
ARISTADA
USA
207533
2015-10-05
RX
SUSPENSION, EXTENDED R...
882MG/3.2ML (275.63MG/...
ARISTADA
USA
207533
2015-10-05
RX
SUSPENSION, EXTENDED R...
1064MG/3.9ML (272.82MG...
ARISTADA
USA
207533
2017-06-05
RX
SUSPENSION, EXTENDED R...
675MG/2.4ML
ARISTADA INITIO KIT
USA
209830
2018-06-29
RX
TABLET, EXTENDED RELEA...
60MG
ISOSORBIDE MONONITRATE
USA
75041
1998-09-22
DISCN
CAPSULE, EXTENDED RELE...
200MG
KETOPROFEN
USA
74879
1997-12-10
DISCN
FOR SUSPENSION, EXTEND...
380MG/VIAL
VIVITROL
USA
21897
2006-04-13
RX

PharmaCompass >>

First
Previous
Next
Last